so, like Coca-Cola.
revenue streams from not only RTU of the syrup (Synopsys kits), but also the rights to bottle (wafers), and get a cut of each one off the retailer's shelf (OEMs).
no, Mark's experience with Cott wouldn't ever have dreamed that up.
not at all...
;-)
GLAL,
R.